15H.01Page 1Patient Partnership — Review
15H.01 · PSS — répétitoire
PSS — review
Personne, Santé, Société (PSS) 2025-2026 · 97 pages
All pages overview. Scroll the whole file, jump by section, or jump directly to a page.
15H.01Page 11Physical Activity & MotivationDual-Process Model
15H.01Page 13Physical Activity & MotivationTEMPA Theory
15H.01Page 18Physical Activity & MotivationSection Conclusions
15H.01Page 19Therapeutic Patient EducationSection Introduction
15H.01Page 20Therapeutic Patient EducationChronic Disease Burden
15H.01Page 23Therapeutic Patient EducationTherapeutic Adherence
15H.01Page 24Therapeutic Patient EducationPerson-Centered Care
15H.01Page 25Therapeutic Patient EducationETP Definition
15H.01Page 26Therapeutic Patient EducationETP Three Pillars
15H.01Page 27Therapeutic Patient EducationETP Process Steps
15H.01Page 28Therapeutic Patient EducationETP Timing
15H.01Page 29Therapeutic Patient EducationETP Impact
15H.01Page 30Patient Knowledge & PartnershipSection Introduction
15H.01Page 31Patient Knowledge & PartnershipSection Objectives
15H.01Page 32Patient Knowledge & PartnershipCommunication in Care
15H.01Page 33Patient Knowledge & PartnershipParadigm Shift (1)
15H.01Page 34Patient Knowledge & PartnershipParadigm Shift (2)
15H.01Page 36Patient Knowledge & PartnershipPatient Revolution
15H.01Page 37Patient Knowledge & PartnershipPatient Knowledge
15H.01Page 40Patient Knowledge & PartnershipPartnership Levels
15H.01Page 41Patient Knowledge & PartnershipPatients in Education
15H.01Page 42Patient Knowledge & PartnershipPatients in Research
15H.01Page 45Rare DiseasesSection Introduction
15H.01Page 46Rare DiseasesRare Diseases Overview
15H.01Page 47Rare DiseasesCollective Frequency
15H.01Page 48Rare DiseasesGene Discovery Pace
15H.01Page 49Rare DiseasesClinical Impact Overview
15H.01Page 50Rare DiseasesPatient Experience
15H.01Page 51Rare DiseasesPatient ExperienceDiagnostic Odyssey
15H.01Page 52Rare DiseasesImportance of Diagnosis
15H.01Page 53Rare DiseasesEuropean Policy
15H.01Page 54Rare DiseasesEuropean PolicyReference Networks (ERN)
15H.01Page 55Rare DiseasesInformation Resources
15H.01Page 56Rare DiseasesOrphanet
15H.01Page 57Rare DiseasesSection Conclusions
15H.01Page 58Digital HealthSection Introduction
15H.01Page 59Digital HealthCourse Overview
15H.01Page 60Digital HealthWhy Digital ToolsMedical Error Scale
15H.01Page 62Digital HealthWhy Digital ToolsHuman-Machine Synergy
15H.01Page 63Digital HealthPrecision Medicine (4P)
15H.01Page 64Digital HealthHealth Information Systems
15H.01Page 67Digital HealthAI Clinical ApplicationsSkin Cancer AI
15H.01Page 70Digital HealthAI Governance & Implications
15H.01Page 72Integrative Chronic Pain ManagementDefinitions
15H.01Page 76Integrative Chronic Pain ManagementPain Components
15H.01Page 80Common Low Back PainSection Introduction
15H.01Page 81Common Low Back PainPrevalence & Burden
15H.01Page 82Common Low Back PainHealth System Goals
15H.01Page 84Common Low Back PainBiopsychosocial Factors
15H.01Page 85Common Low Back PainNon-Drug Management
15H.01Page 86Common Low Back PainSection Conclusions
15H.01Page 87Review QuestionsTherapeutic Adherence MCQ
15H.01Page 88Review QuestionsTherapeutic Adherence MCQAnswer: C
15H.01Page 89Review QuestionsSwiss Health System MCQ
15H.01Page 90Review QuestionsSwiss Health System MCQAnswer: B
15H.01Page 91Review QuestionsLow Back Pain MCQ
15H.01Page 92Review QuestionsLow Back Pain MCQAnswer: D
15H.01Page 93Review QuestionsIntegrative Pain MCQ
15H.01Page 94Review QuestionsIntegrative Pain MCQAnswer: C
15H.01Page 95Review QuestionsMotivation Definition MCQ
15H.01Page 96Review QuestionsMotivation Definition MCQAnswer: B
15H.01Page 97Closing
